The C–T substitution in the distal CACCC box of the β‐globin gene promoter is a common cause of silent β thalassaemia in the Italian population

This paper describes four families of Italian descent in each of which the propositus had the clinical phenotype of thalassaemia intermedia, resulting from the compound heterozygous state for high HbA2β thalassaemia and type I silent β thalassaemia. Direct sequencing on amplified DNA and/or oligonucleotide analysis detected, in all families but one, the compound heterozygous state for codon 39 nonsense mutation and the C‐T substitution at position – 101 in the distal CACCC box of the β‐globin gene promoter (βth–101). Members of these families who are heterozygous for high HbA2β thalassaemia showed the codon 39 nonsense mutation, while those with the clinical phenotype of silent β thalassaemia had the βth–101 mutation. In the remaining family, the propositus and one of his siblings had the compound heterozygous state for a molecularly undefined high HbA2β thalassaemia and the βth–101 mutation in combination with the triple α globin gene arrangement. These patients showed a more severe thalassaemia intermedia like clinical phenotype as compared to those with the same β‐globin genotype and a normal α‐globin gene arrangement. In the families investigated the βth–101 was always associated with haplotype I. A group of patients with thalassaemia intermedia from Southern Italy, either homozygous or heterozygous for haplotype I and in whom previous studies had failed to define the mutation in one of the β thalassaemia globin genes, were screened by oligonucleotide analysis for the presence of the βth–101. Three out of nine were positive. These results indicate that the βth–101 mutation is a common cause of the type I silent β thalassaemia phenotype in the Southern Italian population.

[1]  R. Saiki,et al.  Prenatal diagnosis of β‐thalassaemia in Mediterranean populations by dot blot analysis with DNA amplification and allele specific oligonucleotide probes , 1989, Prenatal diagnosis.

[2]  A. Kutlar,et al.  A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia. , 1989, Blood.

[3]  M. Pirastu,et al.  β THALASSAEMIA MUTATIONS IN MEDITERRANEAN POPULATIONS , 1989, British journal of haematology.

[4]  G. Saglio,et al.  Delineation of specific beta-thalassemia mutations in high-risk areas of Italy: a prerequisite for prenatal diagnosis. , 1988, Blood.

[5]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[6]  S. Liebhaber,et al.  An initiation codon mutation (AUG----GUG) of the human alpha 1-globin gene. Structural characterization and evidence for a mild thalassemic phenotype. , 1987, The Journal of clinical investigation.

[7]  P. Moi,et al.  Molecular characterization of a normal Hb A2β‐thalassaemia determinant in a Sardinian family , 1987, British journal of haematology.

[8]  Henry A. Erlich,et al.  Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes , 1986, Nature.

[9]  P. Moi,et al.  Molecular pathology of haemoglobin H disease in Sardinians , 1986, British journal of haematology.

[10]  A. Cao,et al.  Genetic counseling and genetic heterogeneity in the thalassemias , 1985, Clinical genetics.

[11]  G. Semenza,et al.  The silent carrier allele: β thalassemia without a mutation in the β-globin gene or its immediate flanking regions , 1984, Cell.

[12]  Y. Kan,et al.  Initiation codon mutation as a cause of alpha thalassemia. , 1984, The Journal of biological chemistry.

[13]  S. Orkin,et al.  Base substitution at position -88 in a beta-thalassemic globin gene. Further evidence for the role of distal promoter element ACACCC. , 1984, The Journal of biological chemistry.

[14]  Y. Kan,et al.  Delta +-thalassemia in Sardinia. , 1983, Blood.

[15]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[16]  J. Reiser,et al.  Three regions upstream from the cap site are required for efficient and accurate transcription of the rabbit β-globin gene in mouse 3T6 cells , 1983, Cell.

[17]  D. Weatherall,et al.  Globin gene mapping in normal Hb A2 types of β‐thalassaemia , 1982, British journal of haematology.

[18]  S. Orkin,et al.  Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster , 1982, Nature.

[19]  S. Orkin,et al.  The duplicated human α-globin genes: Their relative expression as measured by RNA analysis , 1981, Cell.

[20]  Tom Maniatis,et al.  The structure and evolution of the human β-globin gene family , 1980, Cell.

[21]  J. Clegg,et al.  A novel α-globin gene arrangement in man , 1980, Nature.

[22]  D. Weatherall,et al.  The Heterogeneity of Normal Hb A2‐β Thalassaemia in Greece , 1979 .

[23]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Trela,et al.  Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus , 1976, Journal of bacteriology.

[25]  T. Huisman,et al.  Microchromatography of hemoglobins. II. A simplified procedure for the determination of hemoglobin A2. , 1975, The Journal of laboratory and clinical medicine.

[26]  M. Pembrey,et al.  Reliable routine estimation of small amounts of foetal haemoglobin by alkali denaturation. , 1972, Journal of clinical pathology.

[27]  E. Schwartz The silent carrier of beta thalassemia. , 1969, The New England journal of medicine.

[28]  A. Kutlar,et al.  An Initiation Codon Mutation as a Cause of a β-Thalassemia , 1990 .

[29]  P. Moi,et al.  Delineation of the molecular basis of delta- and normal HbA2 beta-thalassemia. , 1988, Blood.

[30]  K. Mullis,et al.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. , 1987, Methods in enzymology.

[31]  M. Goossens,et al.  DNA analysis in the diagnosis of hemoglobin disorders. , 1981, Methods in enzymology.

[32]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.